DANIELLE MINCH: Open Payments
NPI 1790083251 · WHEELING, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,689 in 77 payments from 8 companies in 2025. Trend: 2023 $788 · 2024 $4,175 · 2025 $3,689
Speaker / faculty: $2,500Food & beverage: $1,189
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $2,785 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $236 |
| Vanda Pharmaceuticals Inc. | 19 | $229 |
| E.R. Squibb & Sons, L.L.C. | 12 | $144 |
| Lundbeck LLC | 6 | $113 |
| Axsome Therapeutics, Inc. | 3 | $102 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Alkermes, Inc. | 2 | $39 |
Products named: VRAYLAR, CAPLYTA, HETLIOZ, REXULTI, COBENFY, Auvelity, ARISTADA, FANAPT.
Industry payments across WV — which companies pay providers there.
